NRAV and hepatocellular carcinoma: Moreover, we demonstrated that higher expression levels of RHPN1-AS1, LINC01134, NRAV, CMB9-22P13.1, MKLN1-AS, and MAPKAPK5-AS1 were related to shorter OS and DFS time among HCC patients.